Treatment with biologic disease-modifying antirheumatic drugs (bDMARDs), particularly tocilizumab, can suppress inflammation and preserve renal function in a majority of patients with chronic ...

June 27, 2006 (Amsterdam) — The investigative agent eprosidate disodium ( Fibrillex; Neurochem) slows the progression of renal failure, one of the most common complications of amyloid A (AA) ...

One of the most serious complications of rheumatologic and autoimmune diseases can be prevented with biologic drugs, a single-center chart review suggested, and some such products may be more ...

BELLUS Health and Celtic Therapeutics announced that a global confirmatory Phase 3 study was initiated for their orphan status drug, Kiacta (eprodisate), for the treatment of Amyloid A (AA) ...

A number of patients with chronic inflammatory conditions, such as rheumatoid arthritis (RA), develop amyloid A (AA) amyloidosis, a condition characterized by the extracelluar deposition of serum AA ...

FDA Authorizes Device for Dialysis-Related Amyloidosis Patient and graft survival rates were 85.5% and 75.8%, respectively, at 5 years. New study findings support kidney transplantation to treat ...

Neurochem Receives Approvable Letter for Eprodisate for Treatment of AA Amyloidosis; FDA Asks for More Data ECUBLENS, Switzerland, July 17 - Neurochem Limited (Neurochem), a wholly-owned subsidiary of ...

Deposition of fibrils in the kidneys of patients with amyloid A (AA) amyloidosis can lead to proteinuria and progressive loss of renal function. Eprodisate inhibits fibril deposition in the kidneys of ...

Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...

Cardiac amyloidosis is a progressive condition that affects the heart and other organs, but new FDA-approved drugs are prolonging the lives of those affected and early identification is now possible.

Please provide your email address to receive an email when new articles are posted on . The spectrum of conditions under the amyloidosis umbrella can present in myriad ways in patients with rheumatic ...